ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Endocrinology, Diabetes Metabolism

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,604Medicare Part D Prescriptions Filled, Including Refills

Rank: 18 out of 448

$913K Total Retail Price of All Prescriptions

Rank: 26 out of 448

439 Patients Receiving at Least One Drug in Part D
95%Patients 65 Years and Older
90% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

13% of this provider’s 439 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

2% of this provider’s 11,277 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

32% of this provider’s prescriptions were for brand-name drugs, compared to an average of 45%.

Prescription Price

$79 was the average price of a prescription from this provider, compared to $111 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
SIMVASTATIN 457 454 1 4
ZOLPIDEM TARTRATE 337 333 2 37
LEVOTHYROXINE SODIUM 291 274 3 1
OMEPRAZOLE 289 273 4 21
ATENOLOL 277 262 5 29
AMLODIPINE BESYLATE 268 267 6 12
ATORVASTATIN CALCIUM 229 224 7 13
METOPROLOL TARTRATE 226 219 8 44
PRAVASTATIN SODIUM 226 217 8 31
GLIMEPIRIDE 209 205 10 7
PLAVIX 180 180 11 75
CRESTOR 167 164 12 22
HYDROCODONE-ACETAMINOPHEN 166 164 S3 13 33
FUROSEMIDE 157 154 14 25
DONEPEZIL HCL 150 146 15 68
TAMSULOSIN HCL 142 136 16 46
LIPITOR 133 133 17 56
METFORMIN HCL 132 132 18 2
CARVEDILOL 127 127 19 36
LISINOPRIL 121 118 20 14
DIOVAN 120 117 21 23
BENAZEPRIL HCL 120 117 21 38
CLOPIDOGREL 116 116 23 71
NIFEDIPINE ER 114 114 24 130
AMLODIPINE BESYLATE-BENAZEPRIL 111 101 25 130
ZETIA 107 106 26 41
CLONIDINE HCL 102 102 27 72
GABAPENTIN 99 99 28 30
TRAZODONE HCL 96 94 29 145
ALLOPURINOL 96 94 29 48
LOSARTAN-HYDROCHLOROTHIAZIDE 96 96 29 50
ISOSORBIDE MONONITRATE ER 87 87 32 108
CILOSTAZOL 85 82 33 116
VOLTAREN 84 84 34 113
JANUVIA 83 83 35 6
NITROSTAT 78 78 36 267
NEXIUM 75 73 37 63
BENAZEPRIL-HYDROCHLOROTHIAZIDE 75 75 37 229
AZITHROMYCIN 74 72 39 77
ESCITALOPRAM OXALATE 73 72 40 95
FINASTERIDE 73 73 40 136
PANTOPRAZOLE SODIUM 71 71 42 62
HYDROCHLOROTHIAZIDE 70 70 43 27
BENICAR HCT 69 69 44 154
DICYCLOMINE HCL 69 64 44 231
WARFARIN SODIUM 69 69 44 53
ALENDRONATE SODIUM 67 64 47 17
CITALOPRAM HBR 67 63 47 94
CLONIDINE 67 67 47 277
LOSARTAN POTASSIUM 64 64 50 16
AVODART 63 63 51 124
CREON 62 62 52 176
POTASSIUM CHLORIDE 61 61 53 55
SPIRONOLACTONE 60 60 54 110
VYTORIN 58 58 55 107
IBUPROFEN 55 52 56 79
ADVAIR DISKUS 54 42 57 112
LOVASTATIN 54 54 57 40
INSULIN SYRINGE 54 54 57 9
BUMETANIDE 53 53 60 289
DIGOXIN 52 52 61 120
MECLIZINE HCL 52 52 61 137
NAPROXEN 51 49 63 133
EXFORGE HCT 50 50 64 300
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.